Laboratorios Richmond S.A.C.I.F. (BCBA:RICH)
1,455.00
+30.00 (2.11%)
Apr 16, 2025, 4:34 PM BRT
BCBA:RICH Income Statement
Financials in millions ARS. Fiscal year is January - December.
Millions ARS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Revenue | 91,794 | 84,989 | 57,518 | 32,366 | 9,330 | Upgrade
|
Revenue Growth (YoY) | 8.01% | 47.76% | 77.71% | 246.90% | 75.95% | Upgrade
|
Cost of Revenue | 41,558 | 40,233 | 30,340 | 22,765 | 4,783 | Upgrade
|
Gross Profit | 50,237 | 44,757 | 27,178 | 9,602 | 4,547 | Upgrade
|
Selling, General & Admin | 32,973 | 33,217 | 17,935 | 5,110 | 2,218 | Upgrade
|
Other Operating Expenses | 1,698 | - | - | - | - | Upgrade
|
Operating Expenses | 34,671 | 33,217 | 17,935 | 5,110 | 2,218 | Upgrade
|
Operating Income | 15,565 | 11,539 | 9,243 | 4,492 | 2,329 | Upgrade
|
Interest Expense | -3,288 | -18,718 | -4,456 | -1,451 | -506.18 | Upgrade
|
Interest & Investment Income | 7,203 | - | - | - | - | Upgrade
|
Earnings From Equity Investments | -381.49 | -8.39 | 7.33 | - | - | Upgrade
|
Currency Exchange Gain (Loss) | -8,731 | -55,069 | -9,159 | -1,783 | -881.81 | Upgrade
|
Other Non Operating Income (Expenses) | 20,613 | 32,447 | 5,828 | 61.01 | 213.93 | Upgrade
|
EBT Excluding Unusual Items | 30,982 | -29,808 | 1,462 | 1,319 | 1,154 | Upgrade
|
Impairment of Goodwill | -1,828 | -523.72 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | - | 10.26 | 1,019 | 1,436 | -11.36 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | 8.19 | 6.46 | 0.58 | Upgrade
|
Legal Settlements | -574.38 | - | - | - | - | Upgrade
|
Pretax Income | 28,579 | -30,321 | 2,490 | 2,761 | 1,144 | Upgrade
|
Income Tax Expense | 4,768 | -6,528 | 1,993 | 1,590 | 410.18 | Upgrade
|
Earnings From Continuing Operations | 23,811 | -23,794 | 496.36 | 1,172 | 733.5 | Upgrade
|
Minority Interest in Earnings | 33.7 | 164.53 | 12.58 | -19.42 | 0.44 | Upgrade
|
Net Income | 23,845 | -23,629 | 508.94 | 1,152 | 733.94 | Upgrade
|
Net Income to Common | 23,845 | -23,629 | 508.94 | 1,152 | 733.94 | Upgrade
|
Net Income Growth | - | - | -55.83% | 56.98% | 362.98% | Upgrade
|
Shares Outstanding (Basic) | 81 | 81 | 81 | 81 | 81 | Upgrade
|
Shares Outstanding (Diluted) | 81 | 81 | 81 | 81 | 81 | Upgrade
|
Shares Change (YoY) | 0.00% | -0.04% | 0.06% | -0.00% | -0.17% | Upgrade
|
EPS (Basic) | 295.29 | -292.62 | 6.30 | 14.27 | 9.09 | Upgrade
|
EPS (Diluted) | 295.29 | -292.62 | 6.30 | 14.27 | 9.09 | Upgrade
|
EPS Growth | - | - | -55.85% | 56.99% | 363.78% | Upgrade
|
Free Cash Flow | 897.9 | -25,022 | -34,174 | -3,045 | -742.76 | Upgrade
|
Free Cash Flow Per Share | 11.12 | -309.87 | -423.02 | -37.71 | -9.20 | Upgrade
|
Dividend Per Share | - | - | - | - | 0.555 | Upgrade
|
Gross Margin | 54.73% | 52.66% | 47.25% | 29.67% | 48.73% | Upgrade
|
Operating Margin | 16.96% | 13.58% | 16.07% | 13.88% | 24.96% | Upgrade
|
Profit Margin | 25.98% | -27.80% | 0.89% | 3.56% | 7.87% | Upgrade
|
Free Cash Flow Margin | 0.98% | -29.44% | -59.41% | -9.41% | -7.96% | Upgrade
|
EBITDA | 20,077 | 17,533 | 11,522 | 5,165 | 2,584 | Upgrade
|
EBITDA Margin | 21.87% | 20.63% | 20.03% | 15.96% | 27.69% | Upgrade
|
D&A For EBITDA | 4,512 | 5,994 | 2,279 | 673.2 | 255.12 | Upgrade
|
EBIT | 15,565 | 11,539 | 9,243 | 4,492 | 2,329 | Upgrade
|
EBIT Margin | 16.96% | 13.58% | 16.07% | 13.88% | 24.96% | Upgrade
|
Effective Tax Rate | 16.68% | - | 80.06% | 57.57% | 35.87% | Upgrade
|
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.